{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:58:55Z","timestamp":1793480335736,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1245\/s10434-024-14975-w","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:03:07Z","timestamp":1707487387000},"page":"4397-4404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis"],"prefix":"10.1245","volume":"31","author":[{"given":"Matthew L.","family":"Holzner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Droz Dit","family":"Busset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Aldrighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Sapisochin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipe","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel","family":"Schoning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortiz","family":"Schmelzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Nevermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Pratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Florman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Halazun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron E.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parissa","family":"Tabrizian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"14975_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma\u2014evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15:95.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"14975_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"14975_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","volume":"149","author":"MN Mavros","year":"2014","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma. JAMA Surg. 2014;149:565.","journal-title":"JAMA Surg"},{"key":"14975_CR4","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","volume":"29","author":"MC de Jong","year":"2011","unstructured":"de Jong MC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29:3140\u20135.","journal-title":"J Clin Oncol"},{"key":"14975_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jso.25305","volume":"119","author":"LS Hu","year":"2019","unstructured":"Hu LS, et al. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2019;119:21\u20139.","journal-title":"J Surg Oncol"},{"key":"14975_CR6","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07353-4","author":"LS Hu","year":"2019","unstructured":"Hu LS, et al. Recurrence patterns and timing courses following curative-intent resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2019. https:\/\/doi.org\/10.1245\/s10434-019-07353-4.","journal-title":"Ann Surg Oncol"},{"key":"14975_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20:663\u201373.","journal-title":"Lancet Oncol"},{"key":"14975_CR8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268\u201389.","journal-title":"J Hepatol"},{"key":"14975_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/hpb.12441","volume":"17","author":"SM Weber","year":"2015","unstructured":"Weber SM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB. 2015;17:669.","journal-title":"HPB"},{"key":"14975_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, et al. Hepatobiliary Cancers, Version 5.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:541\u201365.","journal-title":"J Natl Compr Canc Netw"},{"key":"14975_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/SLA.0b013e3181e462e6","volume":"252","author":"G Ercolani","year":"2010","unstructured":"Ercolani G, et al. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg. 2010;252:107\u201314.","journal-title":"Ann Surg"},{"key":"14975_CR12","doi-asserted-by":"publisher","first-page":"776863","DOI":"10.3389\/fonc.2021.776863","volume":"11","author":"Y Bekki","year":"2021","unstructured":"Bekki Y, von Ahrens D, Takahashi H, Schwartz M, Gunasekaran G. Recurrent intrahepatic cholangiocarcinoma\u2013review. Front Oncol. 2021;11:776863.","journal-title":"Front Oncol"},{"key":"14975_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.amjsurg.2019.02.015","volume":"219","author":"Y Kitano","year":"2020","unstructured":"Kitano Y, et al. Effectiveness of surgery for recurrent cholangiocarcinoma: a single center experience and brief literature review. Am J Surg. 2020;219:175\u201380.","journal-title":"Am J Surg"},{"key":"14975_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/SLA.0000000000000827","volume":"262","author":"Y Takahashi","year":"2015","unstructured":"Takahashi Y, et al. Surgery for recurrent biliary tract cancer: a single-center experience with 74 consecutive resections. Ann Surg. 2015;262:121\u20139.","journal-title":"Ann Surg"},{"key":"14975_CR15","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1007\/s00268-017-4387-7","volume":"42","author":"T Yoh","year":"2018","unstructured":"Yoh T, et al. Long-term survival of recurrent intrahepatic cholangiocarcinoma: the impact and selection of repeat surgery. World J Surg. 2018;42:1848\u201356.","journal-title":"World J Surg"},{"key":"14975_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.surg.2016.10.024","volume":"161","author":"A Si","year":"2017","unstructured":"Si A, et al. Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: factors associated with long-term outcomes. Surgery. 2017;161:897\u2013908.","journal-title":"Surgery"},{"key":"14975_CR17","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/bjs.8953","volume":"99","author":"L Sulpice","year":"2012","unstructured":"Sulpice L, et al. Treatment of recurrent intrahepatic cholangiocarcinoma. BJS. 2012;99:1711\u20137.","journal-title":"BJS"},{"key":"14975_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1245\/s10434-015-4642-9","volume":"23","author":"G Spolverato","year":"2016","unstructured":"Spolverato G, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol. 2016;23:235\u201343.","journal-title":"Ann Surg Oncol"},{"key":"14975_CR19","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1245\/s10434-016-5454-2","volume":"23","author":"HM Park","year":"2016","unstructured":"Park HM, et al. Outcomes for patients with recurrent intrahepatic cholangiocarcinoma after surgery. Ann Surg Oncol. 2016;23:4392\u2013400.","journal-title":"Ann Surg Oncol"},{"key":"14975_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.amjsurg.2015.07.016","volume":"212","author":"R Souche","year":"2016","unstructured":"Souche R, et al. First and repeat liver resection for primary and recurrent intrahepatic cholangiocarcinoma. Am J Surg. 2016;212:221\u20139.","journal-title":"Am J Surg"},{"key":"14975_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/liv.14682","volume":"41","author":"F Bartsch","year":"2021","unstructured":"Bartsch F, et al. Repeated resection for recurrent intrahepatic cholangiocarcinoma: a retrospective German multicentre study. Liver Int. 2021;41:180\u201391.","journal-title":"Liver Int"},{"key":"14975_CR22","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1245\/s10434-013-3035-1","volume":"20","author":"SJ Zhang","year":"2013","unstructured":"Zhang SJ, et al. Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2013;20:3596\u2013602.","journal-title":"Ann Surg Oncol"},{"key":"14975_CR23","first-page":"138","volume":"19","author":"Y Ge","year":"2020","unstructured":"Ge Y, et al. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: development of a prognostic nomogram. HBPD INT. 2020;19:138\u201346.","journal-title":"HBPD INT"},{"key":"14975_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1245\/s10434-019-08142-9","volume":"27","author":"AC Smart","year":"2020","unstructured":"Smart AC, et al. Hypofractionated radiation therapy for unresectable\/locally recurrent intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2020;27:1122\u20139.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-14975-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-14975-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-14975-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T20:09:19Z","timestamp":1718050159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-14975-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["14975"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-14975-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. Moritz Schmelzle has relevant financial activities outside of the submitted work to disclose from Merck Serono GmbH, Bayer AG, ERBE Elektromedizin GmbH, Amgen Inc., AstraZeneca, Avateramedical GmbH, Johnson & Johnson Medical GmbH, Takeda Pharmaceutical Limited, Olympus K.K., Medtronic GmbH, Intuitive Surgical Inc., Corzamedical, and Baxter Int Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}